Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder

ABSTRACT Objective: This pilot, uncontrolled, open-label study evaluated the safety/tolerability and potential effectiveness of OROS-methylphenidate (OROS-MPH) in adult attention deficit hyperactivity disorder (ADHD). Methods: Adults with DSM-IV-defined ADHD were enrolled in this 38-day study. Retro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current medical research and opinion 2006-12, Vol.22 (12), p.2557-2566
Hauptverfasser:	Fallu, Angelo, Richard, Caroline, Prinzo, Rosanna, Binder, Carin
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Attention Deficit Disorder with Hyperactivity - drug therapy Attention Deficit Disorder with Hyperactivity - psychology Cardiovascular System - drug effects Central Nervous System Stimulants - administration & dosage Central Nervous System Stimulants - adverse effects Central Nervous System Stimulants - therapeutic use Cognition - drug effects Cognition Disorders - drug therapy Cognition Disorders - etiology Delayed-Action Preparations Disability Evaluation Female Humans Male Methylphenidate - administration & dosage Methylphenidate - adverse effects Methylphenidate - therapeutic use Middle Aged Osmosis Patient Satisfaction Pilot Projects Psychological Tests Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!